Cholinergic regulation of vascular endothelial function by human ChAT


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
04 04 2023
Historique:
medline: 31 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: ppublish

Résumé

Endothelial dysfunction and impaired vasodilation are linked with adverse cardiovascular events. T lymphocytes expressing choline acetyltransferase (ChAT), the enzyme catalyzing biosynthesis of the vasorelaxant acetylcholine (ACh), regulate vasodilation and are integral to the cholinergic antiinflammatory pathway in an inflammatory reflex in mice. Here, we found that human T cell ChAT mRNA expression was induced by T cell activation involving the PI3K signaling cascade. Mechanistically, we identified that ChAT mRNA expression was induced following the attenuation of RE-1 Silencing Transcription factor REST-mediated methylation of the ChAT promoter, and that ChAT mRNA expression levels were up-regulated by GATA3 in human T cells. In functional experiments, T cell-derived ACh increased endothelial nitric oxide-synthase activity, promoted vasorelaxation, and reduced vascular endothelial activation and promoted barrier integrity by a cholinergic mechanism. Further, we observed that survival in a cohort of patients with severe circulatory failure correlated with their relative frequency of

Identifiants

pubmed: 36989306
doi: 10.1073/pnas.2212476120
pmc: PMC10083572
doi:

Substances chimiques

Choline O-Acetyltransferase EC 2.3.1.6
Phosphatidylinositol 3-Kinases EC 2.7.1.-
Cholinergic Agents 0
Acetylcholine N9YNS0M02X
RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2212476120

Commentaires et corrections

Type : CommentIn

Références

Am J Med. 2000 Apr 1;108(5):374-80
pubmed: 10759093
J Transl Med. 2011 Jul 20;9:113
pubmed: 21774806
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
Life Sci. 2012 Nov 27;91(21-22):981-5
pubmed: 22569292
J Crit Care. 2019 Aug;52:219-226
pubmed: 31108325
Biochem Med Metab Biol. 1986 Dec;36(3):355-62
pubmed: 3801213
Science. 2019 Feb 8;363(6427):639-644
pubmed: 30733420
J Neuroimmunol. 1998 Feb;82(1):101-107
pubmed: 9526852
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Life Sci. 2003 Mar 28;72(18-19):2021-8
pubmed: 12628452
J Neurosci Res. 1996 Apr 01;44(1):66-72
pubmed: 8926632
Science. 2011 Oct 7;334(6052):98-101
pubmed: 21921156
Eur J Heart Fail. 2015 May;17(5):501-9
pubmed: 25820680
Bioinformatics. 2002 Nov;18(11):1427-31
pubmed: 12424112
Science. 2019 Feb 8;363(6427):585-586
pubmed: 30733405
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75
pubmed: 12588755
J Chromatogr. 1982 Apr 30;239:335-42
pubmed: 7096502
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1410-5
pubmed: 23297238
Crit Rev Immunol. 2020;40(2):135-156
pubmed: 32749092
Cell Physiol Biochem. 2015;37(2):527-36
pubmed: 26330232
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92
pubmed: 31701148
Cell Metab. 2008 Nov;8(5):372-83
pubmed: 19046569
J Physiol. 1953 Apr 28;120(1-2):160-70
pubmed: 13062230
Physiol Rev. 1990 Oct;70(4):921-61
pubmed: 2217559
J Exp Med. 2005 Apr 4;201(7):1113-23
pubmed: 15809354
Nucleic Acids Res. 1991 May 11;19(9):2499
pubmed: 2041787
Nat Rev Immunol. 2007 Oct;7(10):803-15
pubmed: 17893694
Nat Methods. 2020 Feb;17(2):137-145
pubmed: 31792435
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3561-5
pubmed: 7724598
Front Cell Neurosci. 2020 Jan 10;13:580
pubmed: 31998079
J Immunol. 1996 Oct 15;157(8):3472-9
pubmed: 8871646
F1000Res. 2016 Jun 20;5:1438
pubmed: 27508061
Free Radic Biol Med. 2015 Jul;84:154-160
pubmed: 25841777
J Hum Hypertens. 2003 Apr;17(4):223-30
pubmed: 12692566
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G920-G933
pubmed: 27514477
Acta Pharmacol Sin. 2010 Oct;31(10):1389-94
pubmed: 20871620
Life Sci. 2014 Oct 29;116(2):83-9
pubmed: 25261598
EMBO J. 2005 Feb 23;24(4):800-12
pubmed: 15678104
Circulation. 2007 Mar 13;115(10):1285-95
pubmed: 17353456
F1000Res. 2016 Aug 31;5:2122
pubmed: 27909575
J Immunol. 2009 Sep 15;183(6):4031-8
pubmed: 19692637
Nature. 1980 Nov 27;288(5789):373-6
pubmed: 6253831
Curr Opin Neurobiol. 2020 Jun;62:115-121
pubmed: 32126362
Oncotarget. 2017 Jul 19;8(49):84863-84876
pubmed: 29156689
Bioinformatics. 2017 Apr 15;33(8):1179-1186
pubmed: 28088763
N Engl J Med. 2013 Oct 31;369(18):1726-34
pubmed: 24171518
J Biol Chem. 1996 Dec 27;271(52):33358-65
pubmed: 8969196
Elife. 2018 Feb 05;7:
pubmed: 29400648
Cell Death Differ. 2013 Apr;20(4):558-66
pubmed: 23238568
Crit Care Med. 2011 Apr;39(4):878-9
pubmed: 21613831
Oncogene. 2010 Oct 28;29(43):5828-38
pubmed: 20697351
Am J Physiol. 1997 Mar;272(3 Pt 2):H1364-71
pubmed: 9087613
Am J Clin Nutr. 2011 Mar;93(3):564-8
pubmed: 21228267
Nat Cell Biol. 2016 Dec;18(12):1311-1323
pubmed: 27842057
Methods Mol Biol. 2016;1418:335-51
pubmed: 27008022
J Mol Neurosci. 1997 Dec;9(3):223-36
pubmed: 9481623
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13691-6
pubmed: 10570134
Nat Rev Drug Discov. 2019 Oct;18(10):749-769
pubmed: 31541224
Crit Care Med. 2009 Oct;37(10):2827-39
pubmed: 19707124
Blood. 1998 May 15;91(10):3527-61
pubmed: 9572988
Trends Immunol. 2012 Jan;33(1):49-57
pubmed: 22030237
J Neurochem. 1994 May;62(5):1653-63
pubmed: 8158117
Science. 2002 Nov 29;298(5599):1747-52
pubmed: 12399542
Immunology. 2008 Aug;124(4):437-44
pubmed: 18479352
Nat Biotechnol. 2016 Oct;34(10):1066-1071
pubmed: 27617738
Immunity. 2000 Jan;12(1):27-37
pubmed: 10661403
Eur Heart J. 2005 Jan;26(1):65-9
pubmed: 15615801
Pediatr Res. 2017 Jun;81(6):942-947
pubmed: 28157839

Auteurs

Laura Tarnawski (L)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.

Vladimir S Shavva (VS)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.

Eric J Kort (EJ)

DeVos Cardiovascular Program, Van Andel Research Institute and Fredrik Meijer Heart and Vascular Institute/Spectrum Health, Grand Rapids, MI 49503.

Zhengbing Zhuge (Z)

Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Ingrid Nilsson (I)

Vascular Biology Division, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden.

Alessandro L Gallina (AL)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.

David Martínez-Enguita (D)

Bioinformatics Division, Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden.

Benjamin Heller Sahlgren (B)

Vascular Biology Division, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden.

Matthew Weiland (M)

DeVos Cardiovascular Program, Van Andel Research Institute and Fredrik Meijer Heart and Vascular Institute/Spectrum Health, Grand Rapids, MI 49503.

April S Caravaca (AS)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.

Staffan Schmidt (S)

Pronexus Analytical AB, Bromma, 167 33 Stockholm, Sweden.

Ping Chen (P)

Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, 141 52 Stockholm, Sweden.

Katarina Abbas (K)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.

Fu-Hua Wang (FH)

Pronexus Analytical AB, Bromma, 167 33 Stockholm, Sweden.

Osman Ahmed (O)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.

Michael Eberhardson (M)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.
Department of Health, Medicine and Caring Sciences, Linköping University, 581 83 Linköping, Sweden.

Anna Färnert (A)

Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden.

Eddie Weitzberg (E)

Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Mika Gustafsson (M)

Bioinformatics Division, Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden.

Jan Kehr (J)

Vascular Biology Division, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden.
Pronexus Analytical AB, Bromma, 167 33 Stockholm, Sweden.

Stephen G Malin (SG)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.

Henrik Hult (H)

Department of Mathematics, KTH Royal Institute of Technology, 114 28 Stockholm, Sweden.

Mattias Carlström (M)

Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Stefan Jovinge (S)

DeVos Cardiovascular Program, Van Andel Research Institute and Fredrik Meijer Heart and Vascular Institute/Spectrum Health, Grand Rapids, MI 49503.
Cardiovascular Institute, Stanford University, Palo Alto, CA 94305.

Peder S Olofsson (PS)

Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.
Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY 11030.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH